Gold Alexander M
SEC Form 4 insider trading activity
Gold Alexander M has filed 2 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Feb 20, 2026.
On the most recent filing, Gold Alexander M is listed as Director at Mineralys Therapeutics, Inc. Inside the rolling window, Gold Alexander M reported no open-market purchases and 3 open-market sales totaling $1.6M in MLYS. The largest disclosed transaction in the window is a sale of 15,000 MLYS shares on Nov 11, 2025, worth $660K.
Companies traded
Other insiders at MLYS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.6M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Gold Alexander M made?
Gold Alexander M has filed 2 SEC Form 4 filings (10 transaction rows) across 1 company since 2025.
Which companies does Gold Alexander M trade?
Gold Alexander M has filed SEC Form 4 disclosures for 1 company, including MLYS.
When was Gold Alexander M's most recent SEC Form 4 filing?
Gold Alexander M's most recent SEC Form 4 filing on Tracefour is dated Feb 20, 2026.
What is Gold Alexander M's total buy and sell value in the current window?
Inside the rolling retention window, Gold Alexander M bought $0 and sold $1.6M based on SEC Form 4 filings.
What was Gold Alexander M's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 15,000 MLYS shares on 2025-11-11, worth $660K, per SEC Form 4 filings.